Anti-thyroid-stimulating hormone receptor antibodies determined by second-generation assay

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 1, 2007, Pages 26-29

  Mankaï, Amani ^a   Toumi, Dorsaf ^a   Chadli Chaieb, Molka ^b   Ghedira Besbes, Leila ^a   Saad, Fathia ^b   Ouertani, Mohamed ^c   Sfar, Habib ^d   Jeddi, Moncef ^a   Chaieb, Larbi ^b   Ghedira, Ibtissem ^a,b  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c Centre Hospitalo Universitaire Ibn El Jazzar De Kairouan   (Tunisia)

^d Tahar Sfar University Hospital   (Tunisia)

Author keywords

ELISA; Graves' disease; Thyroglobulin antibodies; Thyroperoxydase antibodies; TSH receptor antibodies

Indexed keywords

ANTITHYROID AGENT; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREQUENCY ANALYSIS; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SERUM; TUNISIA; VALIDITY;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GOITER; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; IODIDE PEROXIDASE; MALE; MIDDLE AGED; RECEPTORS, THYROTROPIN; ROC CURVE; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; TUNISIA;

EID: 33846499529     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.016     Document Type: Article

References (18)

1. Schott M, Scherbaum WA, Morgenthaler NG. Thyrotropin receptor autoantibodies in Graves' disease. Trends Endocrinol Metab 2005;16:243-8.
2. Ando T, Latif R, Davies TF. Thyrotropin receptor antibodies: new insights into their actions and clinical relevance. Best Pract Res Clin Endocrinol Metab 2005;19:33-52.
3. Smith BR. Thyroid autoantibodies. Scand J Clin Lab Invest 2001;61:45-52.
4. Orgiazzi J. Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin North Am 2000;29:339-55.
5. Orgiazzi J, Madec AM, Ducottet X. The role of stimulating, function-blocking and growth-blocking anti-TSH receptor antibodies (TRAbs) in GD, Hashimoto's disease and in atrophic thyroiditis. Ann Endocrinol 2003;64:31-6.
6. Costagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 1999;84:90-7.
7. Smith BR, Bolton J, Young S, Collyer A, Weeden A, Bradbury J, et al. A new assay for thyrotropin receptor autoantibodies. Thyroid 2004;14:830-5.
8. Kamijo K. TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroiditis: a comparison of two two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioassay using human recombinant TSH-receptor. Endocr J 2003;50:113-6.
9. Kamijo K, Ishikawa K, Tanaka M. Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Endocr J 2005;52:525-9.
10. Maugendre D, Massart C. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay. Clin Endocrinol 2001;54:89-96.
11. Shibayama K, Ohyama Y, Yokota Y, Ohtsu S, Takubo N, Matsuura N. Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease. Endocr J 2005;52:505-10.
12. Alnaqdy A, Al-Maskari M. Determination of the levels of anti-thyroid-stimulating hormone receptor antibody with thyroid peroxidase antibody in Omani patients with Graves' disease. Med Princ Pract 2005;14:209-12.
13. Schott M, Morgenthaler NG, Fritzen R, Feldkamp J, Willenberg HS, Scherbaum WA, et al. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease. Horm Metab Res 2004;36:92-6.
14. Quadbeck B, Hoermann R, Hahn S, Roggenbuck U, Mann K, Janssen OE. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment. Horm Metab Res 2005;37:745-50.
15. Quadbeck B, Hoermann R, Roggenbuck U, Hahn S, Mann K, Janssen OE; Basedow Study Group. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease. Thyroid 2005;15:1047-54.
16. Hu YM, Liu W, Lu GH. Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves' disease and Hashimoto's hyperthyroidism. Zhonghua Yi Xue Za Zhi 2003;83:940-2.
17. Giovanella L, Ceriani L, Garancini S. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO). Q J Nucl Med 2001;45:115-9.
18. Lian XL, Bai Y, Sun ML, Guo ZS, Dai WX. Clinical validity of anti-thyroperoxidase antibody and anti-thyroglobulin antibody. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2004;26:677-81.